Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports

Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant tre...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research Vol. 44; no. 1_suppl; pp. 67 - 71
Main Authors: De Simone, Clara, Perino, Francesca, Caldarola, Giacomo, D’Agostino, Magda, Peris, Ketty
Format: Journal Article
Language:English
Published: London, England SAGE Publications 01.09.2016
Subjects:
Immuno-Mediated Diseases And Comorbities
Antitumour necrosis factor-α agents
psoriatic arthritis
comorbidities
etanercept
psoriasis
ISSN:0300-0605, 1473-2300, 1473-2300
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects.
AbstractList Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects.
Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects.Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant treatment is debated. We report cases of severe plaque psoriasis in a patient with HIV infection and in a liver transplant recipient who were successfully treated with etanercept, an anti-TNF-α agent, without notable side-effects.
Author De Simone, Clara
Perino, Francesca
Caldarola, Giacomo
D’Agostino, Magda
Peris, Ketty
AuthorAffiliation Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
AuthorAffiliation_xml – name: Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
Author_xml – sequence: 1
  givenname: Clara
  surname: De Simone
  fullname: De Simone, Clara
– sequence: 2
  givenname: Francesca
  surname: Perino
  fullname: Perino, Francesca
– sequence: 3
  givenname: Giacomo
  surname: Caldarola
  fullname: Caldarola, Giacomo
– sequence: 4
  givenname: Magda
  surname: D’Agostino
  fullname: D’Agostino, Magda
– sequence: 5
  givenname: Ketty
  surname: Peris
  fullname: Peris, Ketty
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27683143$$D View this record in MEDLINE/PubMed
BookMark eNp9UUlLJDEUDoMytsvdk-TopTR7VXsQpBkXELz0zDWkUy8aqaqUSUrx30-a1mEU9BTIt733vV20NYQBEDqk5ITSuj4lnBCiiKRSzjmT5AeaUVHzipX_LTRbw9Ua30G7KT0SIpiS7CfaYbVqOBV8hv4sI5jcw5BxcHhMIXqTfMIvPj9gyGaAaGHM2A_Y9_00BBv6MYbeJ2jxaLIvynSGly8BW5MARxhDzGkfbTvTJTh4e_fQ78tfy8V1dXt3dbO4uK2s4CJXNbSgGOOCgXDStoobx4RroKVKGSdYvWqksw3AXIISRlgK84ZyxV2zUsTwPXS-8R2nVQ-tLdNE0-kx-t7EVx2M1x-RwT_o-_CspeRK8roYHL8ZxPA0Qcq6rGah68rmYUqaNnJec0GZKNSj_7P-hbyXWQhqQ7AxpBTBaetzqSiso32nKdHrq-nPVytC8kn47v2NpNpIkrkH_RimOJSev-b_BR4zpxo
CitedBy_id crossref_primary_10_1007_s00296_017_3690_9
crossref_primary_10_1111_ddg_15291_g
crossref_primary_10_3390_biomedicines10112761
crossref_primary_10_3390_biomedicines10020228
crossref_primary_10_1016_j_medmal_2018_11_005
crossref_primary_10_1080_09546634_2018_1535690
crossref_primary_10_1111_ddg_15291
crossref_primary_10_1111_dth_12806
crossref_primary_10_1007_s00403_022_02487_0
crossref_primary_10_1089_apc_2022_0197
crossref_primary_10_1111_dth_12909
crossref_primary_10_1111_ajd_14292
crossref_primary_10_7759_cureus_89494
crossref_primary_10_1016_j_annder_2022_11_010
crossref_primary_10_1111_jdv_19020
crossref_primary_10_1016_j_semarthrit_2021_08_013
crossref_primary_10_1177_2475530320954279
crossref_primary_10_1016_j_clindermatol_2023_12_004
Cites_doi 10.1111/j.1365-4632.2005.02642.x
10.1016/j.transproceed.2012.09.008
10.1016/S1473-3099(10)70101-8
10.1097/TP.0b013e3182247b5f
10.1371/journal.pone.0042011
10.1159/000250839
10.1016/j.jaad.2009.03.047
10.1016/j.jbspin.2006.05.012
10.1136/ard.2007.081513
10.1007/s40257-013-0053-5
10.1111/bjd.12326
10.1517/13543784.2012.669372
ContentType Journal Article
Copyright The Author(s) 2016
The Author(s) 2016.
The Author(s) 2016 2016 SAGE Publications
Copyright_xml – notice: The Author(s) 2016
– notice: The Author(s) 2016.
– notice: The Author(s) 2016 2016 SAGE Publications
DBID AFRWT
AAYXX
CITATION
NPM
7X8
5PM
DOI 10.1177/0300060515593250
DatabaseName Sage Journals Online Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1473-2300
EndPage 71
ExternalDocumentID PMC5536537
27683143
10_1177_0300060515593250
10.1177_0300060515593250
Genre Journal Article
GroupedDBID ---
.55
.GJ
01A
0R~
29K
2WC
44B
53G
54M
5GY
5RE
5VS
7X7
8FI
8FJ
AABQO
AACKU
AAFWJ
AAGGD
AAJIQ
AAJOX
AAJPV
AAJQC
AANSI
AAPEO
AAQQG
AAQXH
AASGM
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWP
ABDWY
ABHKI
ABJNI
ABNCE
ABPGX
ABQKF
ABQXT
ABUWG
ABVFX
ABXGC
ABYTW
ACARO
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACROE
ADBBV
ADEIA
ADMPF
ADOGD
ADQSQ
ADTBJ
ADUKL
AECVZ
AEFTW
AENEX
AERKM
AEUHG
AEWDL
AEXFG
AFCOW
AFKBI
AFKRA
AFKRG
AFPKN
AFRWT
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AUTPY
AYAKG
BAWUL
BCNDV
BDDNI
BENPR
BPHCQ
BSEHC
BVXVI
CBRKF
CCPQU
CORYS
CQQTX
CUTAK
D-I
DC.
DF.
DIK
E3Z
EBD
EBS
EF0
EJD
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HMCUK
HYE
J8X
K.F
KQ8
L7B
MK0
O9-
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
Q1R
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFC
SV3
TR2
TUS
UKHRP
X7M
ZE2
ZGI
AAEJI
AAYXX
ACHEB
AFFHD
CITATION
OVT
AAMGE
AATBZ
ACGZU
ACSIQ
ACUIR
AEDTQ
AEKYL
AEUIJ
AEWHI
AIOMO
BFDSU
DF0
DO-
DV7
NPM
OK1
7X8
5PM
ID FETCH-LOGICAL-c434t-7ede622342e4f5cd63af24f8ed166af427b85fc8ee95e64a4c1e981363f8b60a3
ISICitedReferencesCount 18
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000384827600014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0300-0605
1473-2300
IngestDate Thu Aug 21 13:52:46 EDT 2025
Fri Sep 05 10:49:06 EDT 2025
Wed Feb 19 01:58:25 EST 2025
Sat Nov 29 08:08:33 EST 2025
Tue Nov 18 22:34:20 EST 2025
Tue Jun 17 22:46:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1_suppl
Keywords Antitumour necrosis factor-α agents
psoriatic arthritis
comorbidities
etanercept
psoriasis
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
The Author(s) 2016.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c434t-7ede622342e4f5cd63af24f8ed166af427b85fc8ee95e64a4c1e981363f8b60a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1177/0300060515593250
PMID 27683143
PQID 1859734124
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5536537
proquest_miscellaneous_1859734124
pubmed_primary_27683143
crossref_citationtrail_10_1177_0300060515593250
crossref_primary_10_1177_0300060515593250
sage_journals_10_1177_0300060515593250
PublicationCentury 2000
PublicationDate 20160900
2016-09-00
2016-Sep
20160901
PublicationDateYYYYMMDD 2016-09-01
PublicationDate_xml – month: 9
  year: 2016
  text: 20160900
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
– name: Sage UK: London, England
PublicationTitle Journal of international medical research
PublicationTitleAlternate J Int Med Res
PublicationYear 2016
Publisher SAGE Publications
Publisher_xml – name: SAGE Publications
References Ryan, Abramson, Patel 2012; 21
Collazo, González, Torres 2008; 27
Menon, Van Voorhees, Bebo 2010; 62
Mansouri, Patel, Menter 2013; 169
Fredriksson, Pettersson 1978; 157
Chung, Kim, Kim 2012; 7
Semble, Davis, Feldman 2014; 15
Lee, Heller, Kamangar 2012; 11
Morar, Willis-Owen, Maurer 2010; 10
Hoover 2007; 80
Patel, Weinberg 2008; 82
Brokalaki, Voshege, Witzke 2012; 44
Cepeda, Williams, Ishimori 2008; 67
Lindsey, Weiss, Lee 2014; 13
Sellam, Bouvard, Masson 2007; 74
Ting, Koo 2006; 45
Abadja, Atemkeng, Alamartine 2011; 92
bibr4-0300060515593250
Hoover WD (bibr10-0300060515593250) 2007; 80
Collazo MH (bibr9-0300060515593250) 2008; 27
bibr13-0300060515593250
bibr15-0300060515593250
bibr17-0300060515593250
Lee ES (bibr7-0300060515593250) 2012; 11
bibr1-0300060515593250
bibr3-0300060515593250
Patel RV (bibr14-0300060515593250) 2008; 82
bibr12-0300060515593250
bibr8-0300060515593250
bibr16-0300060515593250
Lindsey SF (bibr5-0300060515593250) 2014; 13
bibr11-0300060515593250
bibr6-0300060515593250
bibr2-0300060515593250
23146521 - Transplant Proc. 2012 Nov;44(9):2776-7
20610329 - Lancet Infect Dis. 2010 Jul;10(7):470-8
24281790 - Am J Clin Dermatol. 2014 Feb;15(1):37-43
19646777 - J Am Acad Dermatol. 2010 Feb;62(2):291-9
21818055 - Transplantation. 2011 Aug 27;92(4):396-403
22395596 - J Drugs Dermatol. 2012 Mar;11(3):413-4
357213 - Dermatologica. 1978;157(4):238-44
18079191 - Ann Rheum Dis. 2008 May;67(5):710-2
17321777 - Joint Bone Spine. 2007 Mar;74(2):197-200
18792543 - Cutis. 2008 Aug;82(2):117-22
22400979 - Expert Opin Investig Drugs. 2012 Apr;21(4):473-87
17956009 - Cutis. 2007 Sep;80(3):211-4
16796629 - Int J Dermatol. 2006 Jun;45(6):689-92
23517414 - Br J Dermatol. 2013 Aug;169(2):481-3
22848688 - PLoS One. 2012;7(7):e42011
19069362 - P R Health Sci J. 2008 Dec;27(4):346-7
25007373 - J Drugs Dermatol. 2014 Jul;13(7):869-71
References_xml – volume: 80
  start-page: 211
  year: 2007
  end-page: 214
  article-title: Etanercept therapy for severe plaque psoriasis in a patient who underwent a liver transplant
  publication-title: Cutis
– volume: 7
  start-page: e42011
  year: 2012
  end-page: e42011
  article-title: Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression
  publication-title: PLoS One
– volume: 13
  start-page: 869
  year: 2014
  end-page: 871
  article-title: Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient
  publication-title: J Drugs Dermatol
– volume: 45
  start-page: 689
  year: 2006
  end-page: 692
  article-title: Use of etanercept in human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) patients
  publication-title: Int J Dermatol
– volume: 15
  start-page: 37
  year: 2014
  end-page: 43
  article-title: Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review
  publication-title: Am J Clin Dermatol
– volume: 27
  start-page: 346
  year: 2008
  end-page: 347
  article-title: Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant
  publication-title: P R Health Sci J
– volume: 92
  start-page: 396
  year: 2011
  end-page: 403
  article-title: Impact of mycophenolic acid and tacrolimus on Th17-related immune response
  publication-title: Transplantation
– volume: 157
  start-page: 238
  year: 1978
  end-page: 244
  article-title: Severe psoriasis – oral therapy with a new retinoid
  publication-title: Dermatologica
– volume: 74
  start-page: 197
  year: 2007
  end-page: 200
  article-title: Use of infliximab to treat psoriatic arthritis in HIV-positive patients
  publication-title: Joint Bone Spine
– volume: 67
  start-page: 710
  year: 2008
  end-page: 712
  article-title: The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease
  publication-title: Ann Rheum Dis
– volume: 62
  start-page: 291
  year: 2010
  end-page: 299
  article-title: Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation
  publication-title: J Am Acad Dermatol
– volume: 11
  start-page: 413
  year: 2012
  end-page: 414
  article-title: Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study
  publication-title: J Drugs Dermatol
– volume: 82
  start-page: 117
  year: 2008
  end-page: 122
  article-title: Psoriasis in the patient with human immunodeficiency virus, part 1: review of pathogenesis
  publication-title: Cutis
– volume: 21
  start-page: 473
  year: 2012
  end-page: 487
  article-title: Current investigational drugs in psoriasis
  publication-title: Expert Opin Investig Drugs
– volume: 44
  start-page: 2776
  year: 2012
  end-page: 2777
  article-title: Treatment of severe psoriasis with etanercept in a pancreas-kidney transplant recipient
  publication-title: Transplant Proc
– volume: 10
  start-page: 470
  year: 2010
  end-page: 478
  article-title: HIV-associated psoriasis: pathogenesis, clinical features, and management
  publication-title: Lancet Infect Dis
– volume: 169
  start-page: 481
  year: 2013
  end-page: 483
  article-title: Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation
  publication-title: Br J Dermatol
– ident: bibr12-0300060515593250
  doi: 10.1111/j.1365-4632.2005.02642.x
– ident: bibr8-0300060515593250
  doi: 10.1016/j.transproceed.2012.09.008
– ident: bibr15-0300060515593250
  doi: 10.1016/S1473-3099(10)70101-8
– volume: 11
  start-page: 413
  year: 2012
  ident: bibr7-0300060515593250
  publication-title: J Drugs Dermatol
– ident: bibr16-0300060515593250
  doi: 10.1097/TP.0b013e3182247b5f
– ident: bibr17-0300060515593250
  doi: 10.1371/journal.pone.0042011
– ident: bibr13-0300060515593250
  doi: 10.1159/000250839
– ident: bibr3-0300060515593250
  doi: 10.1016/j.jaad.2009.03.047
– ident: bibr6-0300060515593250
  doi: 10.1016/j.jbspin.2006.05.012
– volume: 27
  start-page: 346
  year: 2008
  ident: bibr9-0300060515593250
  publication-title: P R Health Sci J
– volume: 80
  start-page: 211
  year: 2007
  ident: bibr10-0300060515593250
  publication-title: Cutis
– ident: bibr4-0300060515593250
  doi: 10.1136/ard.2007.081513
– volume: 82
  start-page: 117
  year: 2008
  ident: bibr14-0300060515593250
  publication-title: Cutis
– ident: bibr2-0300060515593250
  doi: 10.1007/s40257-013-0053-5
– volume: 13
  start-page: 869
  year: 2014
  ident: bibr5-0300060515593250
  publication-title: J Drugs Dermatol
– ident: bibr11-0300060515593250
  doi: 10.1111/bjd.12326
– ident: bibr1-0300060515593250
  doi: 10.1517/13543784.2012.669372
– reference: 17956009 - Cutis. 2007 Sep;80(3):211-4
– reference: 22848688 - PLoS One. 2012;7(7):e42011
– reference: 24281790 - Am J Clin Dermatol. 2014 Feb;15(1):37-43
– reference: 16796629 - Int J Dermatol. 2006 Jun;45(6):689-92
– reference: 22395596 - J Drugs Dermatol. 2012 Mar;11(3):413-4
– reference: 20610329 - Lancet Infect Dis. 2010 Jul;10(7):470-8
– reference: 357213 - Dermatologica. 1978;157(4):238-44
– reference: 25007373 - J Drugs Dermatol. 2014 Jul;13(7):869-71
– reference: 21818055 - Transplantation. 2011 Aug 27;92(4):396-403
– reference: 23146521 - Transplant Proc. 2012 Nov;44(9):2776-7
– reference: 22400979 - Expert Opin Investig Drugs. 2012 Apr;21(4):473-87
– reference: 18079191 - Ann Rheum Dis. 2008 May;67(5):710-2
– reference: 23517414 - Br J Dermatol. 2013 Aug;169(2):481-3
– reference: 19646777 - J Am Acad Dermatol. 2010 Feb;62(2):291-9
– reference: 19069362 - P R Health Sci J. 2008 Dec;27(4):346-7
– reference: 18792543 - Cutis. 2008 Aug;82(2):117-22
– reference: 17321777 - Joint Bone Spine. 2007 Mar;74(2):197-200
SSID ssj0042652
Score 2.1955636
Snippet Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased...
SourceID pubmedcentral
proquest
pubmed
crossref
sage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 67
SubjectTerms Immuno-Mediated Diseases And Comorbities
Title Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
URI https://journals.sagepub.com/doi/full/10.1177/0300060515593250
https://www.ncbi.nlm.nih.gov/pubmed/27683143
https://www.proquest.com/docview/1859734124
https://pubmed.ncbi.nlm.nih.gov/PMC5536537
Volume 44
WOSCitedRecordID wos000384827600014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1473-2300
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0042652
  issn: 0300-0605
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6wQMviG_Kx2QkqIS6aE3s2DFvE2zwUEolMtS3KB_OiNQlpenG9vfwj3KOHWddGRoPvESVmziu79fz-e78O4ReB7CKk9ynDvWzxKGSM0fEue8k3ojkYCa5qSZJGvPJJJjNxLTX-9WehTmb87IMzs_F4r-KGtpA2Oro7D-I23YKDfAZhA5XEDtcbyZ4mzreJDNX8EpFOtI4XCWYgjqTRfk5CnU2pFJJ5csKxA2mp2FZbdLkwp_VMIU1rg0rXGPGFmsuxRMT9zEcQtbX_EEOvwIqtPtU5QTFnU5eFk35b13jQ9aXcofieabyURr79mMBuvuksh2-8fj-cQUKSj_8OT42vgXjwnCZzdFqtS7lxIG9kA7QyD-0GVWtqSJbSA5rVfj0kvbVhT02F4UmLA3aTJHPqJI2YLP6o24BbIP-ky_R4dF4HIUHs3Cw-OGo0mQqhG_qtGyhWx73RdDu2_VyDxZOU9bJjreLhe9dfeW67bOxodnMy72UXNjYO-E9dNdIGO9rgN1HPVk-QIOpZjq_2MVhd3Cv3sUDPO040C8eom8WhbjKsUUhVijEHQpxUeINFOIWhe8wYBArDGKDwUfo6PAgfP_JMSU8nJQSunK4zCQDC5R6kuZ-mjES5x7NA5m5jMU59XgSqCxCKYUvGY1p6koRuISBokjYKCaP0XYJ4HyKcBZkLCCZTBTDkJBxIDzPjUcJmLy-EDnvo712cqPU8NurMivzyG0p7a-Io4_e2icWmtvlL_e-auUVwVyoqBpMVXVaR2DwCk5UEfc-eqLlZ3vzYDNPYEfSR3xNsvYGRe6-_k1ZfG9I3n2fMJ_ArxooDERGwdTXDvDZDQb4HN3p_n4v0PZqeSpfotvp2aqolztoi8-CnQbcvwEYZtFw
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+psoriasis+with+etanercept+in+immunocompromised+patients%3A+Two+case+reports&rft.jtitle=Journal+of+international+medical+research&rft.au=De+Simone%2C+Clara&rft.au=Perino%2C+Francesca&rft.au=Caldarola%2C+Giacomo&rft.au=D%27Agostino%2C+Magda&rft.date=2016-09-01&rft.issn=1473-2300&rft.eissn=1473-2300&rft.volume=44&rft.issue=1+suppl&rft.spage=67&rft_id=info:doi/10.1177%2F0300060515593250&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-0605&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-0605&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-0605&client=summon